Aspire Biopharma Holdings, Inc.
ASBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$13 | $4 | -$1 |
| Dep. & Amort. | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 |
| Change in WC | $1 | $1 | $0 |
| Other Non-Cash | $9 | -$6 | $0 |
| Operating Cash Flow | -$2 | -$1 | -$0 |
| Investing Activities | – | – | – |
| PP&E Inv. | $0 | $0 | -$5 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 |
| Inv. Sales/Matur. | $14 | $0 | $0 |
| Other Inv. Act. | $0 | $285 | $0 |
| Investing Cash Flow | $14 | $285 | -$5 |
| Financing Activities | – | – | – |
| Debt Repay. | $2 | $0 | -$0 |
| Stock Issued | $0 | $0 | $1 |
| Stock Repurch. | -$14 | -$285 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $4 |
| Financing Cash Flow | -$12 | -$285 | $5 |
| Forex Effect | -$0 | $0 | $0 |
| Net Chg. in Cash | $0 | -$0 | -$0 |
| Supplemental Information | – | – | – |
| Beg. Cash | $0 | $0 | $0 |
| End Cash | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$1 | -$5 |